296 related articles for article (PubMed ID: 34560863)
1. Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma.
Hua JL; Ye XF; Du CL; Xie N; Zhang JQ; Li M; Zhang J
BMC Pulm Med; 2021 Sep; 21(1):302. PubMed ID: 34560863
[TBL] [Abstract][Full Text] [Related]
2. Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial.
Hua J; Zhang W; Cao HF; Du CL; Ma JY; Zuo YH; Zhang J
BMJ Open; 2020 May; 10(5):e034804. PubMed ID: 32385061
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients.
Harb HS; Laz NI; Rabea H; Abdelrahim MEA
Eur J Pharm Sci; 2020 Apr; 147():105298. PubMed ID: 32151707
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.
Ghosh S; Pleasants RA; Ohar JA; Donohue JF; Drummond MB
Int J Chron Obstruct Pulmon Dis; 2019; 14():585-595. PubMed ID: 30880948
[TBL] [Abstract][Full Text] [Related]
5. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
[TBL] [Abstract][Full Text] [Related]
6. Suboptimal peak inspiratory flow rate: a noticeable risk factor for inhaler concordance in patients with chronic airway diseases.
Meng W; Xiong R; Zhao Z; Zeng H; Chen Y
BMJ Open Respir Res; 2024 Apr; 11(1):. PubMed ID: 38642917
[TBL] [Abstract][Full Text] [Related]
7. Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.
Ghosh S; Ohar JA; Drummond MB
J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):381-387. PubMed ID: 28933581
[TBL] [Abstract][Full Text] [Related]
8. Can patients achieve sufficient peak inspiratory flow rate (PIFR) with Turbuhaler® during acute exacerbation of asthma?
Mohd Rhazi NA; Muneswarao J; Abdul Aziz F; Ibrahim B; Kamalludin A; Soelar SA
J Asthma; 2023 Aug; 60(8):1608-1612. PubMed ID: 36650693
[TBL] [Abstract][Full Text] [Related]
9. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
[TBL] [Abstract][Full Text] [Related]
10. Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea.
Moon JY; Kim SH; Kim Y; Lee H; Rhee CK; Ra SW; Lee CY; Park JH; Park YB; Yoo KH
Pulm Pharmacol Ther; 2024 Jun; 85():102298. PubMed ID: 38604404
[TBL] [Abstract][Full Text] [Related]
11. Determinants of Suboptimal Peak Inspiratory Flow Rates among Patients with Chronic Obstructive Pulmonary Disease in Southwest, Nigeria.
Arawomo AO; Erhabor GE; Tanimowo MO; Awopeju OF; Adewole OO; Adeniyi BO; Afolabi BA; Ekundayo MW
West Afr J Med; 2023 May; 40(5):553-561. PubMed ID: 37247343
[TBL] [Abstract][Full Text] [Related]
12. Peak Inspiratory Flow Measured at Different Inhaler Resistances in Patients with Asthma.
Haughney J; Lee AJ; McKnight E; Pertsovskaya I; O'Driscoll M; Usmani OS
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):890-896. PubMed ID: 33011302
[TBL] [Abstract][Full Text] [Related]
13. Inappropriate Peak Inspiratory Flow Rate with Dry Powder Inhaler in Chronic Obstructive Pulmonary Disease.
Chen SY; Huang CK; Peng HC; Yu CJ; Chien JY
Sci Rep; 2020 Apr; 10(1):7271. PubMed ID: 32350352
[TBL] [Abstract][Full Text] [Related]
14. Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases.
Kawamatawong T; Khiawwan S; Pornsuriyasak P
J Asthma Allergy; 2017; 10():17-21. PubMed ID: 28260934
[TBL] [Abstract][Full Text] [Related]
15. Wixela Inhub: Dosing Performance
Cooper A; Parker J; Berry M; Wallace R; Ward J; Allan R
J Aerosol Med Pulm Drug Deliv; 2020 Dec; 33(6):323-341. PubMed ID: 32429788
[No Abstract] [Full Text] [Related]
16. Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: An observational comparative study.
Ramadan WH; Sarkis AT
Chron Respir Dis; 2017 Aug; 14(3):309-320. PubMed ID: 28774201
[TBL] [Abstract][Full Text] [Related]
17. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Factors Affecting the Optimal and Non-optimal Peak Inspiratory Flow Rate in Stable and Exacerbation Phases of Chronic Obstructive Pulmonary Disease and Bronchial Asthma in India.
Murugaiya S; Murugesan B; S P
Cureus; 2024 Apr; 16(4):e58670. PubMed ID: 38774171
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
20. Inappropriate Peak Inspiratory Flow Rate in the Patients with Stable Chronic Obstructive Pulmonary Disease in Korea.
Youn SH; Kim HJ; Park JS; Park SH; Kwon YS; Kim MA
Tuberc Respir Dis (Seoul); 2024 Apr; ():. PubMed ID: 38659389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
